Health / Aduhelm New Alzheimer's Drug Spurs Big Concerns, an Investigation 2 House committees launch inquiry into approval, cost of Biogen's Aduhelm By Jenn Gidman Posted Jun 30, 2021 6:35 AM CDT Copied Back